| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 750035 | Null | 0.0339770934764516 | 0.36951393 |
| NSC 750395 | Null | 0.0339770934764516 | 0.4395616 |
| NSC 758376 | 2-(1-(2-fluorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide | 0.0339770934764516 | 0.39775226 |
| NSC 763266 | Null | 0.0339770934764516 | 0.28914882 |
| NSC 84145 | Null | 0.0339770934764516 | 0.17753418 |
| NSC 97960 | Null | 0.0339770934764516 | 0.36626098 |
| NSC 734307 | 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide | 0.0385067071027343 | 0.3052657 |
| NSC 740973 | 6-(3-Azidopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0385067071027343 | -0.15452898 |
| NSC 743434 | 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one | 0.0385067071027343 | 0.4809078 |
| NSC 747447 | 3,19-(4-N,N-dimethylamino)benzylidineandrographolide | 0.0385067071027343 | 0.29186832 |